Tissue Regenix Group (LSE:TRX) Long-Term Capital Lease Obligation : £2.55 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Long-Term Capital Lease Obligation?

Tissue Regenix Group's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was £2.55 Mil.

Tissue Regenix Group's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (£2.64 Mil) to Jun. 2023 (£2.49 Mil) but then increased from Jun. 2023 (£2.49 Mil) to Dec. 2023 (£2.55 Mil).

Tissue Regenix Group's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (£2.53 Mil) to Dec. 2022 (£2.64 Mil) but then declined from Dec. 2022 (£2.64 Mil) to Dec. 2023 (£2.55 Mil).

Tissue Regenix Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for Tissue Regenix Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Long-Term Capital Lease Obligation Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.29

2.53

2.64

2.55

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															2.53	2.67	2.64	2.49	2.55

Tissue Regenix Group (LSE:TRX) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Tissue Regenix Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.